Samsung Biologics Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Hi, I'm TJ Park, senior country officer for JPMorgan Korea. Today, I'm very pleased and honored to introduce John Rim as a presenter for Samsung Biologics. John took the helm of Samsung Biologics in December 2020 to lead the exco's phase as the new CEO and President of the company. Since he joined Samsung Biologics in 2018, he contributed to the expansion of the global business portfolio and operational excellence as Executive Vice President. John has served in a variety of senior leadership roles throughout his 35 years of experience in the biopharmaceutical industry.
Today, he will share his vision and Samsung Biologics' strategic direction in this challenging environment. Without further ado, let me hand it over to John Rim.
Thank you, TJ, for the kind introduction. Good morning, good evening, everybody. It's great to be here with you today. I'm John Rim, CEO of Samsung Biologics.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |